Tyler Jacks
Tyler Jacks is a David H. Koch Professor of Biology at the Massachusetts Institute of Technology (MIT), a long-time HHMI investigator, and Founding Director of the David H. Koch Institute for Integrative Cancer Research, which brings together biologists and engineers to improve detection, diagnosis, and treatment of cancer. Dr. Jacks is a member of the board of directors of Thermo Fisher Scientific and Amgen, two of the major biotechnology corporations in the world. He is the President of Break Through Cancer and a member of the Board of Overseers, the larger of two governing boards of Harvard University. Provided by Wikipedia
Showing 1 - 6 results of 6 for search 'Tyler E. Jacks.', query time: 0.03s
Refine Results
-
1
A Conditional System to Specifically Link Disruption of Protein-Coding Function with Reporter Expression in Mice by Shin-Heng Chiou, Caroline Kim-Kiselak, Viviana I. Risca, Megan K. Heimann, Chen-Hua Chuang, Aurora A. Burds, William J. Greenleaf, Tyler E. Jacks, David M. Feldser, Monte M. Winslow
Published 2014-06-01
Article -
2
Functional analysis of K-ras in the mouse by gene targeting by Johnson, Leisa Kay
Published 2008Other Authors: “…Tyler E. Jacks.…”
Thesis -
3
Creating a mouse model of neurofibromatosis type I : pathological and functional analysis of a tumor suppressor gene by Shih, T. Shane (Tzeshan Shane), 1969-
Published 2009Other Authors: “…Tyler E. Jacks.…”
Thesis -
4
Analysis of p53 function in cellular responses to microtubule-acting drugs by Lanni, Jennifer Sue, 1969-
Published 2009Other Authors: “…Tyler E. Jacks.…”
Thesis -
5
Functional analysis of the Neurofibromatosis Type II tumor suppressor gene by Shaw, Reuben J. (Reuben James), 1972-
Published 2014Other Authors: “…Tyler E. Jacks.…”
Thesis -
6
AGO2 in overexpression exhibits oncogenic functions KrasG̳1̳2̳D̳ -associated mouse tumor models by Thai, Kevin K. (Kevin Kinh)
Published 2018Other Authors: “…Tyler E. Jacks and Phillip A. Sharp.…”
Thesis